| Literature DB >> 33180746 |
Bryce A Schuler1, A Christian Habermann2, Erin J Plosa1, Chase J Taylor2, Christopher Jetter1, Nicholas M Negretti1, Meghan E Kapp3, John T Benjamin1, Peter Gulleman1, David S Nichols2, Lior Z Braunstein4, Alice Hackett1, Michael Koval5, Susan H Guttentag1, Timothy S Blackwell2,6,7, Steven A Webber1, Nicholas E Banovich8, Jonathan A Kropski2,6,7, Jennifer Ms Sucre1,6.
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) novel coronavirus 2019 (COVID-19) global pandemic has led to millions of cases and hundreds of thousands of deaths. While older adults appear at high risk for severe disease, hospitalizations and deaths due to SARS-CoV-2 among children have been relatively rare. Integrating single-cell RNA sequencing (scRNA-seq) of developing mouse lung with temporally resolved immunofluorescence in mouse and human lung tissue, we found that expression of SARS-CoV-2 Spike protein primer TMPRSS2 was highest in ciliated cells and type I alveolar epithelial cells (AT1), and TMPRSS2 expression increased with aging in mice and humans. Analysis of autopsy tissue from fatal COVID-19 cases detected SARS-CoV-2 RNA most frequently in ciliated and secretory cells in airway epithelium and AT1 cells in peripheral lung. SARS-CoV-2 RNA was highly colocalized in cells expressing TMPRSS2. Together, these data demonstrate the cellular spectrum infected by SARS-CoV-2 in lung epithelium and suggest that developmental regulation of TMPRSS2 may underlie the relative protection of infants and children from severe respiratory illness.Entities:
Keywords: Expression profiling; Pulmonology
Mesh:
Substances:
Year: 2021 PMID: 33180746 PMCID: PMC7773394 DOI: 10.1172/JCI140766
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808